These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3594815)

  • 1. Ability of the 1(2)s rule to detect substandard performance in interlaboratory proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):788-91. PubMed ID: 3594815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory proficiency-testing programs: a computer model to assess their capability to correctly characterize intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):784-7. PubMed ID: 3594814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of alternative rules (other than the 1(2)s) for evaluating interlaboratory performance data.
    Ehrmeyer SS; Laessig RH; Schell K
    Clin Chem; 1988 Feb; 34(2):250-6. PubMed ID: 3342504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the ability of proficiency testing programs to determine intralaboratory performance. Peer group statistics vs clinical usefulness limits.
    Ehrmeyer SS; Laessig RH
    Arch Pathol Lab Med; 1988 Apr; 112(4):444-8. PubMed ID: 3355346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the use of fixed limits to characterize intralaboratory performance by proficiency testing.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Oct; 33(10):1901-2. PubMed ID: 3665047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of computer modeling to predict the magnitude of intralaboratory error tolerated by proposed CDC interlaboratory proficiency testing performance criteria.
    Laessig RH; Ehrmeyer SS
    Clin Chem; 1988 Sep; 34(9):1849-53. PubMed ID: 2843307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralaboratory performance requirements necessary to pass proficiency testing: CAP-1990 vs CLIA-1967 (March 14, 1990) formats compared.
    Laessig RH; Ehrmeyer SS; Leinweber JE
    Clin Chem; 1992 Jun; 38(6):895-903. PubMed ID: 1597015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of several rules for self-interpretation of proficiency testing data.
    Carey RN; Cembrowski GS; Garber CC; Zaki Z
    Arch Pathol Lab Med; 2005 Aug; 129(8):997-1003. PubMed ID: 16048412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of interlaboratory precision criteria in measuring intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1985 Aug; 31(8):1352-4. PubMed ID: 3926347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficiency test performance as a predictor of accuracy of routine patient testing for theophylline.
    Jenny RW; Jackson KY
    Clin Chem; 1993 Jan; 39(1):76-81. PubMed ID: 8419063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1990 Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass.
    Ehrmeyer SS; Laessig RH; Leinweber JE; Oryall JJ
    Clin Chem; 1990 Oct; 36(10):1736-40. PubMed ID: 2170059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of asbestos fiber counting laboratories in the NIOSH proficiency analytical testing (PAT) program.
    Schlecht PC; Shulman SA
    Am Ind Hyg Assoc J; 1986 May; 47(5):259-69. PubMed ID: 3012990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory and intralaboratory variabilities in the Environmental Lead Proficiency Analytical Testing (ELPAT) Program.
    Schlecht PC; Song R; Groff JH; Feng HA; Esche CA
    Am Ind Hyg Assoc J; 1997 Nov; 58(11):779-86. PubMed ID: 9373923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of regional quality control programs in the practice of laboratory medicine in the United States.
    Lawson NS; Haven GT
    Am J Clin Pathol; 1976 Jul; 66(1):268-75. PubMed ID: 937271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1999 Aug; 21(4):389-94. PubMed ID: 10442691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the rigor and appropriateness of CLIA '88 toxicology proficiency testing standards.
    Jenny RW; Jackson KY
    Clin Chem; 1992 Apr; 38(4):496-500. PubMed ID: 1568313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.
    Cembrowski GS; Hackney JR; Carey N
    Arch Pathol Lab Med; 1993 Apr; 117(4):437-43. PubMed ID: 8466413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proficiency testing performance: a case study with modeling.
    Waugh JM; Collier CP; Day AG; Waugh M; Raymond MJ
    Clin Biochem; 2002 Sep; 35(6):447-53. PubMed ID: 12413605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of intralaboratory bias and imprecision on laboratories' ability to meet medical usefulness limits.
    Ehrmeyer SS; Laessig RH
    Am J Clin Pathol; 1988 Jan; 89(1):14-8. PubMed ID: 3337048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing global data to estimate analytical performance on the Sigma scale: A global comparative analysis of methods, instruments, and manufacturers through external quality assurance and proficiency testing programs.
    Westgard SA
    Clin Biochem; 2016 Jun; 49(9):699-707. PubMed ID: 26948097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.